Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study

Background: Few antimicrobial resistance profile data exist for Mozambique. Limited antimicrobial stewardship and a lack of guidelines favour near anarchic antibiotic use. We aimed to study antibiotic selection rationale, empirical therapy, and use of cultures in Maputo Central Hospital, Maputo, Moz...

Full description

Bibliographic Details
Main Authors: Clotilde Nhatave, MD, Gilberto Lucas, MD, Inara Wate, MD, Zaira Sáu, MD, Sam Patel, MD, Emília V Noormahomed, PhD, Robert T Schooley, MD, Randy Taplitz, MD
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X19300993
_version_ 1828910789297176576
author Clotilde Nhatave, MD
Gilberto Lucas, MD
Inara Wate, MD
Zaira Sáu, MD
Sam Patel, MD
Emília V Noormahomed, PhD
Robert T Schooley, MD
Randy Taplitz, MD
author_facet Clotilde Nhatave, MD
Gilberto Lucas, MD
Inara Wate, MD
Zaira Sáu, MD
Sam Patel, MD
Emília V Noormahomed, PhD
Robert T Schooley, MD
Randy Taplitz, MD
author_sort Clotilde Nhatave, MD
collection DOAJ
description Background: Few antimicrobial resistance profile data exist for Mozambique. Limited antimicrobial stewardship and a lack of guidelines favour near anarchic antibiotic use. We aimed to study antibiotic selection rationale, empirical therapy, and use of cultures in Maputo Central Hospital, Maputo, Mozambique. Methods: We recruited adults admitted to Maputo Central Hospital's medical wards between February and April, 2018, and who were prescribed antibiotics. We collected data from patient charts and prescription sheets and studied the profile of acute bacterial infections, antibiotic treatment choices, and possible treatment errors. Findings: We included 232 patients (12·5% of admissions). Of these, 143 (61·6%) were HIV infected, more than half (64%) with a CD4 count of less than 200 cells/μL. Diagnosed infections included: community-acquired pneumonia (106 patients [44·1%]), bacterial meningitis (50 [15·1%]), aspiration pneumonia (42 [12·7%]), acute enteritis (38 [11·5%]), chronic enteritis (7 [2·1%]), urinary tract infection (19 [5·7%]), soft tissue infections (10 [3%]), sepsis (11 [3·3%]), brain abscess (3 [0·9%]), neutropenic fever (3 [0·9%]), and otitis with effusion (1 [0·9%]). Antibiotics were prescribed for 52 patients (22·4%) who did not have a recorded infection on the medical chart. Eight prescriptions were meant for infection prophylaxis in patients with hepatic encephalopathy, stroke, diabetic ketoacidosis, or haematological malignancies. Of the included inpatients, 12·1% (28) died, 77·2% (179) were discharged home improved, 10·8% (25) transferred to lower acuity hospitals, and 4·3% (10) transferred to a tuberculosis hospital. We identified 347 prescriptions for the 232 patients. One antibiotic was prescribed in 56·9% (132) of cases and two or more were prescribed to 37·1% (86) and 6% (14), respectively. Ceftriaxone (176 prescriptions [50·7%]) and metronidazole (57 [16·4%]) were most frequently prescribed. We identified 46 prescriptions (12·7%) for patients with no indication recorded on their chart. In 42 cases (12%), the antibiotic choice was not consistent with international guidelines. Incorrect duration of therapy was specified in 8 cases (2%). Glomerular filtration rate estimations were seldomly used to adjust dosage. Blood cultures were rarely ordered (2 [0·86%]). CSF was cultured in 38 patients, with no positive findings. Interpretation: A scarcity of antimicrobial drugs, shortages of qualified staff, a lack of local stewardship of antimicrobial programmes, and poor laboratory capacity encourage the overuse of empirical treatment rather than treatment decisions based on evidence and laboratory findings. Findings suggest the need for continued education, and accurate and updated hospital antimicrobial resistance algorithms for best clinical practices. Funding: Fogarty International Center from the NIH D43TW009343 and the UCGHI.
first_indexed 2024-12-13T18:50:17Z
format Article
id doaj.art-cdab48da8d3f46cc83f91e4af915043b
institution Directory Open Access Journal
issn 2214-109X
language English
last_indexed 2024-12-13T18:50:17Z
publishDate 2019-03-01
publisher Elsevier
record_format Article
series The Lancet Global Health
spelling doaj.art-cdab48da8d3f46cc83f91e4af915043b2022-12-21T23:34:58ZengElsevierThe Lancet Global Health2214-109X2019-03-017S14Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational studyClotilde Nhatave, MD0Gilberto Lucas, MD1Inara Wate, MD2Zaira Sáu, MD3Sam Patel, MD4Emília V Noormahomed, PhD5Robert T Schooley, MD6Randy Taplitz, MD7Maputo Central Hospital, Maputo, Mozambique; Correspondence to: Dr Clotilde Nhatave, Maputo Central Hospital, Agostinho Neto Avenue 164, Maputo 1164, MozambiqueMaputo Central Hospital, Maputo, MozambiqueMaputo Central Hospital, Maputo, MozambiqueMaputo Central Hospital, Maputo, MozambiqueUniversity of Eduardo Mondlane, Mozambique, Maputo, MozambiqueUniversity of Eduardo Mondlane, Mozambique, Maputo, MozambiqueUniversity of California, San Diego, CA, USAUniversity of California, San Diego, CA, USABackground: Few antimicrobial resistance profile data exist for Mozambique. Limited antimicrobial stewardship and a lack of guidelines favour near anarchic antibiotic use. We aimed to study antibiotic selection rationale, empirical therapy, and use of cultures in Maputo Central Hospital, Maputo, Mozambique. Methods: We recruited adults admitted to Maputo Central Hospital's medical wards between February and April, 2018, and who were prescribed antibiotics. We collected data from patient charts and prescription sheets and studied the profile of acute bacterial infections, antibiotic treatment choices, and possible treatment errors. Findings: We included 232 patients (12·5% of admissions). Of these, 143 (61·6%) were HIV infected, more than half (64%) with a CD4 count of less than 200 cells/μL. Diagnosed infections included: community-acquired pneumonia (106 patients [44·1%]), bacterial meningitis (50 [15·1%]), aspiration pneumonia (42 [12·7%]), acute enteritis (38 [11·5%]), chronic enteritis (7 [2·1%]), urinary tract infection (19 [5·7%]), soft tissue infections (10 [3%]), sepsis (11 [3·3%]), brain abscess (3 [0·9%]), neutropenic fever (3 [0·9%]), and otitis with effusion (1 [0·9%]). Antibiotics were prescribed for 52 patients (22·4%) who did not have a recorded infection on the medical chart. Eight prescriptions were meant for infection prophylaxis in patients with hepatic encephalopathy, stroke, diabetic ketoacidosis, or haematological malignancies. Of the included inpatients, 12·1% (28) died, 77·2% (179) were discharged home improved, 10·8% (25) transferred to lower acuity hospitals, and 4·3% (10) transferred to a tuberculosis hospital. We identified 347 prescriptions for the 232 patients. One antibiotic was prescribed in 56·9% (132) of cases and two or more were prescribed to 37·1% (86) and 6% (14), respectively. Ceftriaxone (176 prescriptions [50·7%]) and metronidazole (57 [16·4%]) were most frequently prescribed. We identified 46 prescriptions (12·7%) for patients with no indication recorded on their chart. In 42 cases (12%), the antibiotic choice was not consistent with international guidelines. Incorrect duration of therapy was specified in 8 cases (2%). Glomerular filtration rate estimations were seldomly used to adjust dosage. Blood cultures were rarely ordered (2 [0·86%]). CSF was cultured in 38 patients, with no positive findings. Interpretation: A scarcity of antimicrobial drugs, shortages of qualified staff, a lack of local stewardship of antimicrobial programmes, and poor laboratory capacity encourage the overuse of empirical treatment rather than treatment decisions based on evidence and laboratory findings. Findings suggest the need for continued education, and accurate and updated hospital antimicrobial resistance algorithms for best clinical practices. Funding: Fogarty International Center from the NIH D43TW009343 and the UCGHI.http://www.sciencedirect.com/science/article/pii/S2214109X19300993
spellingShingle Clotilde Nhatave, MD
Gilberto Lucas, MD
Inara Wate, MD
Zaira Sáu, MD
Sam Patel, MD
Emília V Noormahomed, PhD
Robert T Schooley, MD
Randy Taplitz, MD
Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study
The Lancet Global Health
title Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study
title_full Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study
title_fullStr Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study
title_full_unstemmed Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study
title_short Profile of bacterial infectious disease and antimicrobial choices in an urban hospital at Maputo, Mozambique: a prospective observational study
title_sort profile of bacterial infectious disease and antimicrobial choices in an urban hospital at maputo mozambique a prospective observational study
url http://www.sciencedirect.com/science/article/pii/S2214109X19300993
work_keys_str_mv AT clotildenhatavemd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT gilbertolucasmd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT inarawatemd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT zairasaumd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT sampatelmd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT emiliavnoormahomedphd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT roberttschooleymd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy
AT randytaplitzmd profileofbacterialinfectiousdiseaseandantimicrobialchoicesinanurbanhospitalatmaputomozambiqueaprospectiveobservationalstudy